Status:
COMPLETED
Immunogenicity Induced by COVID-19 Vaccines in Mexican Population
Lead Sponsor:
National Polytechnic Institute, Mexico
Conditions:
COVID-19 Vaccine
Eligibility:
All Genders
18+ years
Brief Summary
To determine the gene expression of anti-spike IgG through PCR-RT in patients vaccinated with the 4 types of vaccines available in Mexico Oxford/AstraZeneca (ChAdOx1 nCoV-19), Centro Nacional Gamaleya...
Detailed Description
80 subjects with full vaccination schedule will be included, 20 per group To know the gene expression of IgG anti-spike through PCR-RT in patients vaccinated with the 4 types of vaccines available in ...
Eligibility Criteria
Inclusion
- \- Mexican people.
- \- Over 18 years of age.
- \- With complete vaccination schedule against COVID-19.
- \- Allowing peripheral blood samples to be taken.
- \- To sign an informed consent form.
- \- To agree to participate in the protocol.
Exclusion
- \- Persons with incomplete vaccination schedule against COVID-19.
- \- Persons who have 30 +/- 5 days of having completed the vaccination scheme against COVID-19.
- \- People under treatment with any immunosuppressive drug.
- People who refuse to sign the informed consent form.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06597370
Start Date
September 1 2021
End Date
December 21 2021
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Escuela Superior de Medicina, Instituto Politécnico Nacional
Mexico City, Mexico, 11340